Tracheostomy in Mechanically Ventilated Patients With SARS-CoV-2-ARDS: Focus on Tracheomalacia.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 23 9 2021
medline: 23 11 2021
entrez: 22 9 2021
Statut: ppublish

Résumé

The SARS-CoV-2 pandemic increased the number of patients needing invasive mechanical ventilation, either through an endotracheal tube or through a tracheostomy. Tracheomalacia is a rare but potentially severe complication of mechanical ventilation, which can significantly complicate the weaning process. The aim of this study was to describe the strategies of airway management in mechanically ventilated patients with respiratory failure due to SARS-CoV-2, the incidence of severe tracheomalacia, and investigate the factors associated with its occurrence. This retrospective, single-center study was performed in an Italian teaching hospital. All adult subjects admitted to the ICU between February 24, 2020, and June 30, 2020, treated with invasive mechanical ventilation for respiratory failure caused by SARS-CoV-2 were included. Clinical data were collected on the day of ICU admission, whereas information regarding airway management was collected daily. A total of 151 subjects were included in the study. On admission, ARDS severity was mild in 21%, moderate in 62%, and severe in 17% of the cases, with an overall mortality of 40%. A tracheostomy was performed in 73 (48%), open surgical technique in 54 (74%), and percutaneous Ciaglia technique in 19 (26%). Subjects who had a tracheostomy performed had, compared to the other subjects, a longer duration of mechanical ventilation and longer ICU and hospital stay. Tracheomalacia was diagnosed in 8 (5%). The factors associated with tracheomalacia were female sex, obesity, and tracheostomy. In our population, approximately 50% of subjects with ARDS due to SARS-CoV-2 were tracheostomized. Tracheostomized subjects had a longer ICU and hospital stay. In our population, 5% were diagnosed with tracheomalacia. This percentage is 10 times higher than what is reported in available literature, and the underlying mechanisms are not fully understood.

Sections du résumé

BACKGROUND
The SARS-CoV-2 pandemic increased the number of patients needing invasive mechanical ventilation, either through an endotracheal tube or through a tracheostomy. Tracheomalacia is a rare but potentially severe complication of mechanical ventilation, which can significantly complicate the weaning process. The aim of this study was to describe the strategies of airway management in mechanically ventilated patients with respiratory failure due to SARS-CoV-2, the incidence of severe tracheomalacia, and investigate the factors associated with its occurrence.
METHODS
This retrospective, single-center study was performed in an Italian teaching hospital. All adult subjects admitted to the ICU between February 24, 2020, and June 30, 2020, treated with invasive mechanical ventilation for respiratory failure caused by SARS-CoV-2 were included. Clinical data were collected on the day of ICU admission, whereas information regarding airway management was collected daily.
RESULTS
A total of 151 subjects were included in the study. On admission, ARDS severity was mild in 21%, moderate in 62%, and severe in 17% of the cases, with an overall mortality of 40%. A tracheostomy was performed in 73 (48%), open surgical technique in 54 (74%), and percutaneous Ciaglia technique in 19 (26%). Subjects who had a tracheostomy performed had, compared to the other subjects, a longer duration of mechanical ventilation and longer ICU and hospital stay. Tracheomalacia was diagnosed in 8 (5%). The factors associated with tracheomalacia were female sex, obesity, and tracheostomy.
CONCLUSIONS
In our population, approximately 50% of subjects with ARDS due to SARS-CoV-2 were tracheostomized. Tracheostomized subjects had a longer ICU and hospital stay. In our population, 5% were diagnosed with tracheomalacia. This percentage is 10 times higher than what is reported in available literature, and the underlying mechanisms are not fully understood.

Identifiants

pubmed: 34548406
pii: respcare.09063
doi: 10.4187/respcare.09063
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1797-1804

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have no conflicts to disclose.

Auteurs

Marcello Guarnieri (M)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Patrizia Andreoni (P)

Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Hedwige Gay (H)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Riccardo Giudici (R)

Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Maurizio Bottiroli (M)

Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Michele Mondino (M)

Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Gianpaolo Casella (G)

Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Osvaldo Chiara (O)

Department of Emergency and Trauma Surgery, Niguarda Hospital, University of Milan, Milan, Italy.

Oscar Morelli (O)

Department of Otolaryngology, Niguarda Hospital, Milan, Italy.

Serena Conforti (S)

Department of Thoracic Surgery, Niguarda Hospital, Milan, Italy.

Thomas Langer (T)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Thomas.Langer@unimib.it.
Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Roberto Fumagalli (R)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Department of Anesthesia and Intensive Care Medicine, Niguarda Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH